ArticleProceedings of the National Academy of Sciences of the United States of America2026

A pharmacovigilance data-driven approach to reveal high fatal adverse events following checkpoint immunotherapy.

Zhen Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.